Cite
HARVARD Citation
Felip, E. et al. (2020). CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations. European journal of cancer. pp. 160-172. [Online].